SR3335
RORα partial inverse agonist / SR3335 (293753-05-6) is a selective RORα partial inverse agonist (IC50 = 480 nM) – displays no activity at RORß, RORγ, or FXR.1 It was able to suppress gluconeogenesis in diet-induced obese mice. SR3335 was able to upregulate uncoupling protein 1 (UCP1), a unique mitochondrial protein devoted to thermogenesis, in wild type mice leading to decreased body weight and fat mass.2,3 It inhibited the development of mouse and human TH17 cells in vitro and in vivo leaving thymic T cells intact.4 SR3335’s ability to block pathogenic, but not protective TH17 cell function makes it an important new tool in the study of TH17-mediated inflammatory and autoimmune diseases.
Biochemicals & reagents
293753-05-6
ML176
1 Kumar et al. (2011), Identification of SR3335 (ML176): a synthetic RORα selective inverse agonist; ACS Chem. Biol. 6 218 2 Monnier et al. (2018), The nuclear retinoid-related orphan receptor RORα controls circadian thermogenic programming in white fat depots; Physiol. Rep. 6 e13678 3 Auclair et al. (2021), Pharmacological modulation of ROR α controls fat browning, adaptive thermogenesis, and body weight in mice; Am. J. Physiol. Endocrinol. 320 E219 4 Wang et al. (2021), Genetic and pharmacological inhibition of the nuclear receptor RORα regulates TH17 driven inflammatory disorders; Nat. Commun. 12 76
-20°C
TARGET: Retinoid receptor and related; Transcription factor -- PATHWAY: Transcription; Mitochondrial function; Glucose metabolism -- RESEARCH AREA: Immunology -- DISEASE AREA: Obesity; Inflammation